Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson's Disease
- Details
- Category: Eli Lilly and Company

Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005
- Details
- Category: Pfizer

Bayer affirms the positive benefit-risk profile of its drospirenone- containing oral contraceptives
- Details
- Category: Bayer

Lundbeck's partner Mochida receives approval of Lexapro in Japan
- Details
- Category: Lundbeck

Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
- Details
- Category: Amgen

Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
- Details
- Category: Amgen

Abbott Reports 17.4 Percent Sales Growth
- Details
- Category: Abbott

More Pharma News ...
- Novartis makes strong start for the year
- GSK welcomes key agreement to support global preparedness against pandemic influenza
- Roche Group's first-quarter 2011 sales on track for full-year targets
- Pfizer Announces Top-Line Results of Third Phase 3 Clinical Trial of Tofacitinib (CP-690,550)
- Bayer's Rivaroxaban Submitted for Approval in Japan
- Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease
- Forest Laboratories Completes Acquisition of Clinical Data, Inc.